With Focused ESWT
(Extracorporeal Shock Wave Therapy)
In Athletic Therapy, Rehabilitation
and Musculoskeletal conditions
Conventional Distributor Model
Advanced MedTech is the producer and takes on the other aspects such as branding, marketing and local registration, while partners are only required to sell the products.
Advanced MedTech believes in teamwork and flexibility, and we offer customizable partnership scenarios.
Advanced MedTech is the producer and leaves the other aspects, such as branding, marketing, and local registration, to the partners.
Advanced MedTech is open to the partnership model that will work best for you. Our vision is to be one of the world’s best suppliers of medical solutions, and we welcome like-minded organizations who want to be a part of this journey with us.
For more enquiries, please feel free to reach out to our team at
email@example.com to discuss how we can help you increase your sales and add value to your customers through
Grow your business.
Increase your revenue.
Did you know that statistics from WHO show that approximately 1.71 billion people suffer from musculoskeletal (MSK) conditions worldwide, establishing itself as the leading contributor to disability globally?¹
Based on studies conducted on the market for shock wave therapy, global shock wave sales are expected to reach USD$697.55M by 2026.²
people suffer from musculoskeletal conditions worldwide
By 2026, global shock wave
sales are expected to reach
Collaborating with a
global leader in
Advanced MedTech is a global medical technology leader with a core focus in urology devices and contract manufacturing services. The Group serves millions of patients and physicians in 100 countries worldwide and has a reported USD$280M in revenue during the 2022 fiscal year, which ended in 31 March 2022.³ Advanced MedTech makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world. Advanced MedTech is a wholly owned subsidiary of Temasek and has recently acquired WIKKON, a high and new technology enterprise with medical device research, engineering and manufacturing capabilities. Advanced MedTech also offers low intensity shock wave treatment options in the form of ESWT (extracorporeal shock wave therapy).
Advanced MedTech offers two devices for ESWT treatment:
Dornier Aries 2
Dornier Aries 2
Why treat with ESWT
ESWT is a safe and non-invasive procedure that introduces shock waves through the skin into the injured part of the body, delivering effective therapeutic results. ESWT has been proven effective in the treatment of certain injuries over the last two decades by enhancing healing through revascularization and tissue stimulation, allowing for a treatment that boasts minimal complications, great pain control and effective function recovery.⁴
Healing process of focused ESWT
Studies show that focused shock waves are effective in reaching deep tissue easily, in contrast to radial pressure waves, which are effective only on the surface. Focused ESWT induces the body’s own healing response, allowing the body to repair itself via: ⁵ ⁻ ⁶
healing and angiogenesis
Stem cell recruitment
Nerve cell repair and pain reduction
Dornier Aries 2
Dornier Aries 2 is a 100% natural, drug-free treatment device that stimulates the healing of problematic tissue, addresses pain, and supports patient tissue recovery using non-invasive methods. Being one system with multiple solutions, Dornier Aries 2 is clinically proven to treat a wide range of indications, ranging from urological issues to musculoskeletal conditions and even chronic pelvic pain syndrome.⁷⁻⁸ Backed by German engineering, Dornier Aries 2 stands out from its competitors with consistent output of shock waves throughout the device’s lifespan and a superb durability of 2,000,000 shocks, plus its unique features: the SmartFocus and KoolShield technologies.
New and improved way to change specifications of treatment plans
Active protection and cooling of
(electromagnetic shock wave emitter)
HK.SWT-300 is a clinically proven⁹ focused ESWT device that stands out in the field. It is used to treat a comprehensive range of orthopedic, sports and MSK conditions such as ligament/tendon injuries and tennis elbow.
Unique product features include
Compact device with an intuitive user interface and “plug and play” capability make it a perfect fit for hospitals, small healthcare establishments, or even at home
Each HK.SWT-300 comes equipped with a well-designed trolley that allows for easy and convenient moving of the device as well as storage space for accessories
Large LCD screen offers easy viewing of the screen from a distance
Articulated arm with flexible joints allows for hands-free easy movement during treatment and access to hard-to-reach areas
Near-zero start-up time
No gel pads or consumables required
HK.SWT-300 is a fuss-free, convenient device that is very easy to operate and requires no prior preparation.
Maintenance of the product is simple, and we recommend a regular change of applicator head to maintain operational efficiency.
1. Musculoskeletal health. (2022, July 14). Retrieved November 30, 2022, from https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions
2. Custom-Global Extracorporeal Shock Wave Therapy Device Professional. Survey Report 2021, Forecast to 2026 (2021). Market Research.
3. Daga, A., & Ngui, Y. (2022, November 14). Exclusive: Temasek considers sale of Advanced Medtech, likely valued at about $1 bln - sources. Reuters. Retrieved January 12,
2023, from https://www.reuters.com/markets/deals/exclusive-temasek-weighs-sale-advanced-medtech-likely-valued-about-1-bln-sources-2022-11-14/
4. Auersperg, V., & Trieb, K. (2020). Extracorporeal shock wave therapy: an update. EFORT Open Reviews, 5(10), 584-592.
5. Simplicio, C. L., Purita, J., Murrell, W., Santos, G. S., Dos Santos, R. G., & Lana, J.F. S. D. (2020). Extracorporeal shock wave therapy mechanisms in musculoskeletalregenerative
medicine. Journal of Clinical Orthopaedicsand Trauma, 11,S309-S318. https://doi.org/10.1016/j.jcot.2020.02.004
6.Sukubo, N. G., Tibalt, E., Respizzi, S., Locati, M., & d’Agostino, M.C. (2015).Effect of shock waves on macrophages: a possible role in tissue regenerationand remodeling.
International Journal of Surgery, 24, 124-130. https://doi.org/10.1016/j.ijsu.2015.07.719
7. Porst, H. (2021). Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), peyronie’s disease (pd), and sexual
rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients.
Sexual Medicine Reviews, 9(1), 93-122.
8. Mykoniatis, I., Kalyvianakis, D., Zilotis, F., Kapoteli, P., Fournaraki, A., Poulios, E., & Hatzichristou, D. (2021). Evaluation of a low-intensity shockwave therapy for chronic
prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Prostate Cancer and Prostatic Diseases, 24(2), 370-379.
9. Clinical trials performed in China. Data on file, available upon request.